- Report
- July 2023
- 129 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
- Report
- January 2019
- 35 Pages
Global
From €910EUR$1,000USD£780GBP
Seroxat (paroxetine) is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder. It is also used to treat generalized anxiety disorder in adults. Seroxat is one of the most commonly prescribed drugs for mental disorders, and is available in both generic and brand-name forms.
Seroxat is generally well-tolerated, with few side effects. Common side effects include nausea, headache, insomnia, and sexual dysfunction. Serious side effects include increased risk of suicidal thoughts and behaviors, serotonin syndrome, and withdrawal symptoms.
The Seroxat market is highly competitive, with many pharmaceutical companies offering generic and brand-name versions of the drug. Some of the major players in the market include GlaxoSmithKline, Pfizer, Eli Lilly, and AstraZeneca. Other companies include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more